RSS

Catalent Pharma Solutions

Stephen Tindal, director of science and technology at Catalent Pharma Solutions discusses what methods can be used to classify a drug’s solubility and bridge the divide between disciplines during development phases. Read more

Opinion

In this article, Stephie Lee, scientist, Oral Drug Delivery at Catalent Pharma Solutions, goes through the important considerations for a successful GLP toxicology study outcome. Read more

Latest Issue

Catalent Pharma Solutions, global provider of advanced delivery technologies and development solutions, has signed a commercial manufacturing agreement with Aucta Pharmaceuticals to formulate vigabatrin into a novel dosage form. Read more

News

Catalent Pharma Solutions, global provider of advanced delivery technologies and development solutions, has announced it will adopt Berkeley Lights’ Beacon optofluidic platform to accelerate its cell line development workflow Read more

Technology

Here, Pingyun (P.Y.) Chen, PhD, director of Early Development at Catalent Pharma Solutions, details some of the important considerations required in product development and how a holistic approach can help save money and time in the long run. Read more

Opinion

The first patient has been enrolled by InterveXion in STAMPOUT — the first trial in methamphetamine users of the first-in-class anti-methamphetamine antibody IXT-m200 — the news of which Catalent Pharma Solutions has welcomed. Read more

News

Catalent Pharma Solutions has completed the second phase of its expansion programme, increasing the controlled-substance and controlled-temperature storage capabilities for its clinical supply business at its Kansas City facility. Read more

News

Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions, and Valerius Biopharma, a Swiss biopharmaceutical company, are collaborating on the development and manufacture of speciality biosimilars Read more

News

Catalent Pharma Solutions has revealed its plans to invest $5 million in the creation of a new drug development centre of excellence (CoE) at its Somerset, New Jersey facility and headquarters Read more

News

Catalent Pharma Solutions has signed a multi-year agreement with Grid Therapeutics for the development and manufacture of a lead therapeutic candidate for the treatment of solid tumours. Read more

News

Global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, Catalent Pharma Solutions, has entered into a commercial manufacturing agreement with US WorldMeds for lofexidine. Read more

News

Catalent Pharma Solutions is increasing its spray drying capacity at its Pharmatek, San Diego, California facility in response to market demand for solubility enhancement solutions. Read more

News

Global CDMO Catalent has announced its enrollment in the Pharmaceutical Supply Chain Initiative (PSCI) Read more

News

Catalent Pharma Solutions has entered into an exclusive, long term supply agreement to produce Pfizer’s over-the-counter (OTC) heartburn treatment, Nexium Control (esomeprazole) Read more

News

Catalent Pharma Solutions has announced the multi-site expansion of its analytical and process development capabilities for biologics Read more

News